Seawolf Therapeutics Announces Series A Financing
Seawolf Therapeutics raised a Series A with participation from Versant Ventures, MPM BioImpact, Novartis Venture Fund, Eli Lilly, CRISPR Therapeutics and others.
Seawolf Therapeutics raised a Series A with participation from Versant Ventures, MPM BioImpact, Novartis Venture Fund, Eli Lilly, CRISPR Therapeutics and others.